Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Israel | 11 | 2021 | 2751 | 0.54 | Why? |
| Urinary Tract Infections | 1 | 2019 | 534 | 0.50 | Why? |
| Enterobacteriaceae Infections | 1 | 2019 | 529 | 0.49 | Why? |
| Drug Resistance, Multiple, Bacterial | 2 | 2019 | 1115 | 0.45 | Why? |
| Medical Staff, Hospital | 1 | 2021 | 1258 | 0.42 | Why? |
| Mass Vaccination | 1 | 2021 | 1101 | 0.42 | Why? |
| Sexually Transmitted Diseases | 1 | 2018 | 694 | 0.41 | Why? |
| Community-Acquired Infections | 2 | 2019 | 2328 | 0.33 | Why? |
| Anti-Bacterial Agents | 5 | 2019 | 10083 | 0.23 | Why? |
| Adverse Outcome Pathways | 1 | 2021 | 63 | 0.22 | Why? |
| Single Molecule Imaging | 1 | 2021 | 126 | 0.21 | Why? |
| Abortion, Septic | 1 | 2019 | 5 | 0.21 | Why? |
| Primary Health Care | 1 | 2018 | 4839 | 0.20 | Why? |
| Metronidazole | 1 | 2019 | 59 | 0.20 | Why? |
| Ampicillin | 1 | 2019 | 73 | 0.20 | Why? |
| Gentamicins | 1 | 2019 | 76 | 0.19 | Why? |
| Wound Infection | 1 | 2019 | 66 | 0.19 | Why? |
| Ureaplasma urealyticum | 1 | 2018 | 10 | 0.19 | Why? |
| Mycoplasma hominis | 1 | 2018 | 15 | 0.19 | Why? |
| Trichomonas vaginalis | 1 | 2018 | 19 | 0.19 | Why? |
| Pelvic Inflammatory Disease | 1 | 2018 | 24 | 0.19 | Why? |
| Microbiota | 2 | 2021 | 1240 | 0.19 | Why? |
| Mycoplasma genitalium | 1 | 2018 | 30 | 0.19 | Why? |
| Intrauterine Devices | 1 | 2018 | 38 | 0.19 | Why? |
| Health Personnel | 4 | 2021 | 29646 | 0.18 | Why? |
| Leptospira | 1 | 2018 | 48 | 0.18 | Why? |
| Water Pollution | 1 | 2018 | 51 | 0.18 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.18 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 9706 | 0.17 | Why? |
| Medical Tourism | 1 | 2018 | 53 | 0.17 | Why? |
| Chorioamnionitis | 1 | 2017 | 50 | 0.17 | Why? |
| Leptospirosis | 1 | 2018 | 103 | 0.17 | Why? |
| Drug Resistance, Multiple | 1 | 2018 | 156 | 0.17 | Why? |
| Chlamydia trachomatis | 1 | 2018 | 172 | 0.16 | Why? |
| Neisseria gonorrhoeae | 1 | 2018 | 142 | 0.16 | Why? |
| Bacteriophages | 1 | 2019 | 268 | 0.16 | Why? |
| Fetal Membranes, Premature Rupture | 1 | 2017 | 122 | 0.16 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.15 | Why? |
| Incidental Findings | 1 | 2020 | 487 | 0.15 | Why? |
| Enterobacteriaceae | 1 | 2019 | 395 | 0.14 | Why? |
| Bacterial Infections | 2 | 2018 | 2229 | 0.13 | Why? |
| Microbial Sensitivity Tests | 2 | 2019 | 2886 | 0.13 | Why? |
| Healthy Volunteers | 1 | 2019 | 1444 | 0.12 | Why? |
| Staphylococcus aureus | 1 | 2019 | 844 | 0.12 | Why? |
| Communicable Diseases, Imported | 1 | 2020 | 843 | 0.12 | Why? |
| Dysbiosis | 1 | 2017 | 685 | 0.11 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 1261 | 0.11 | Why? |
| Bacteria | 2 | 2018 | 1897 | 0.10 | Why? |
| Diagnostic Tests, Routine | 1 | 2021 | 2643 | 0.10 | Why? |
| Staphylococcal Infections | 1 | 2019 | 1099 | 0.10 | Why? |
| Drug Resistance, Bacterial | 1 | 2019 | 1414 | 0.10 | Why? |
| Military Personnel | 1 | 2019 | 1097 | 0.09 | Why? |
| Bacteremia | 1 | 2019 | 1372 | 0.09 | Why? |
| Retrospective Studies | 10 | 2021 | 105322 | 0.09 | Why? |
| Polymerase Chain Reaction | 2 | 2020 | 6740 | 0.08 | Why? |
| Logistic Models | 2 | 2019 | 9089 | 0.08 | Why? |
| Female | 19 | 2021 | 380317 | 0.08 | Why? |
| Placenta | 1 | 2017 | 1531 | 0.08 | Why? |
| Carrier State | 1 | 2018 | 2100 | 0.08 | Why? |
| Diagnosis, Differential | 1 | 2021 | 7220 | 0.08 | Why? |
| RNA, Ribosomal, 16S | 2 | 2021 | 793 | 0.08 | Why? |
| Outpatients | 1 | 2019 | 3417 | 0.07 | Why? |
| Male | 17 | 2021 | 367725 | 0.07 | Why? |
| Electronic Health Records | 1 | 2019 | 3492 | 0.07 | Why? |
| Humans | 26 | 2021 | 930598 | 0.07 | Why? |
| Nasopharynx | 2 | 2021 | 10224 | 0.07 | Why? |
| Diarrhea | 1 | 2017 | 2743 | 0.07 | Why? |
| Schools | 1 | 2020 | 4187 | 0.07 | Why? |
| Adult | 16 | 2021 | 244371 | 0.07 | Why? |
| Machine Learning | 1 | 2020 | 4395 | 0.07 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.07 | Why? |
| DNA, Bacterial | 2 | 2018 | 835 | 0.06 | Why? |
| Magnetic Resonance Imaging | 1 | 2020 | 6551 | 0.06 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.06 | Why? |
| Feces | 1 | 2017 | 4235 | 0.06 | Why? |
| Lung | 3 | 2020 | 31049 | 0.06 | Why? |
| Base Sequence | 2 | 2021 | 3581 | 0.06 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.06 | Why? |
| Molecular Diagnostic Techniques | 1 | 2018 | 4239 | 0.06 | Why? |
| Risk Factors | 2 | 2019 | 71621 | 0.05 | Why? |
| DNA, Fungal | 1 | 2018 | 95 | 0.05 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.05 | Why? |
| Polyproteins | 1 | 2021 | 814 | 0.04 | Why? |
| ROC Curve | 2 | 2020 | 6024 | 0.04 | Why? |
| APACHE | 1 | 2020 | 682 | 0.04 | Why? |
| Observer Variation | 1 | 2020 | 622 | 0.04 | Why? |
| DNA, Ribosomal | 1 | 2017 | 112 | 0.04 | Why? |
| Apgar Score | 1 | 2017 | 77 | 0.04 | Why? |
| Streptococcus | 1 | 2017 | 76 | 0.04 | Why? |
| Hysterectomy | 1 | 2018 | 171 | 0.04 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.04 | Why? |
| Mycobacterium | 1 | 2018 | 143 | 0.04 | Why? |
| Immune Sera | 1 | 2021 | 884 | 0.04 | Why? |
| Acinetobacter Infections | 1 | 2019 | 273 | 0.04 | Why? |
| Single-Blind Method | 1 | 2020 | 1283 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Acinetobacter baumannii | 1 | 2019 | 378 | 0.04 | Why? |
| Water Microbiology | 1 | 2018 | 248 | 0.04 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.04 | Why? |
| Respiratory Distress Syndrome, Newborn | 1 | 2017 | 124 | 0.04 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.04 | Why? |
| Child | 6 | 2020 | 70012 | 0.04 | Why? |
| Arabs | 1 | 2018 | 298 | 0.04 | Why? |
| Treatment Failure | 1 | 2021 | 2106 | 0.04 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.04 | Why? |
| Fungi | 1 | 2018 | 471 | 0.04 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.04 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Cattle | 1 | 2018 | 1336 | 0.03 | Why? |
| Klebsiella pneumoniae | 1 | 2019 | 658 | 0.03 | Why? |
| Infant, Newborn | 3 | 2020 | 23105 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Area Under Curve | 1 | 2020 | 2564 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.03 | Why? |
| Infant | 3 | 2020 | 30274 | 0.03 | Why? |
| Tertiary Care Centers | 2 | 2020 | 8248 | 0.03 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Gestational Age | 1 | 2017 | 1488 | 0.03 | Why? |
| Sequence Analysis, RNA | 1 | 2020 | 2290 | 0.03 | Why? |
| Aged | 7 | 2021 | 215776 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2017 | 11559 | 0.03 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.03 | Why? |
| Risk Management | 1 | 2018 | 1044 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Phylogeny | 2 | 2020 | 13341 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2018 | 27595 | 0.03 | Why? |
| Swine | 1 | 2018 | 3352 | 0.02 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.02 | Why? |
| Basic Reproduction Number | 1 | 2020 | 2676 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2021 | 3444 | 0.02 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.02 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Liver | 1 | 2021 | 4007 | 0.02 | Why? |
| Parents | 1 | 2020 | 2758 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.02 | Why? |
| Pregnancy | 2 | 2019 | 23879 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2019 | 7268 | 0.02 | Why? |
| Survival Analysis | 1 | 2019 | 7592 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Pregnancy Outcome | 1 | 2017 | 3803 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.02 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.02 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.02 | Why? |
| Germany | 1 | 2018 | 9196 | 0.02 | Why? |
| Fever | 1 | 2018 | 7795 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.01 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.01 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.01 | Why? |
| Travel | 1 | 2018 | 7220 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Epidemics | 1 | 2018 | 6407 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Cross Infection | 1 | 2019 | 8675 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.01 | Why? |
| Public Health | 1 | 2018 | 16359 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.01 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |